Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
TIE-2 (also known as TEK or Angiopoietin-1 receptor) is a receptor tyrosine kinase primarily expressed in endothelial cells. It plays a crucial role in blood vessel formation, remodeling, and maintenance of vascular integrity. TIE-2 is activated by angiopoietins, particularly Angiopoietin-1, which promotes vessel stability and quiescence. Angiopoietin-2 can act as either an agonist or antagonist depending on the context. Dysregulation of TIE-2 is implicated in various diseases, including vascular malformations and tumor angiogenesis, making it a potential therapeutic target.
Agonist or antagonist of TIE-2 signaling, depending on the specific agent and context. Agonists promote receptor oligomerization and autophosphorylation, while antagonists block ligand binding or downstream signaling.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on TIE-2 receptor (Tie2).